Patents by Inventor Yann Louchart

Yann Louchart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds which have activity at M1 receptor and their uses in medicine
    Publication number: 20120316202
    Abstract: Compounds of the general formula And their use in the treatment of psychotic disorders and cognitive impairment are disclosed.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 13, 2012
    Inventors: David Gwyn COOPER, Ian Thomson Forbes, Vincenzo Garzya, Jian Jin, Yann Louchart, Graham Walker, Paul Adrian Wyman
  • Compounds which have activity at M1 receptor and their uses in medicine
    Publication number: 20120309789
    Abstract: Compounds of general formula and their use in the treatment of psychotic disorders and cognitive impairment, are disclosed.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 6, 2012
    Inventors: David Gwyn COOPER, Ian Thomas FORBES, Vicenzo GARZYA, Jian JIN, Yann LOUCHART, Graham WALKER, Paul Adrian WYMAN
  • BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
    Publication number: 20120041027
    Abstract: Compounds of formula (I) and salts and solvates are provided: wherein Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.
    Type: Application
    Filed: October 27, 2011
    Publication date: February 16, 2012
    Inventors: David Gwyn COOPER, Ian Thomson Forbes, Vincenzo Garzya, Jian Jin, Yann Louchart, Graham Walker, Paul Adrian Wyman
  • BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
    Publication number: 20120041028
    Abstract: Compounds of formula (I), salts and solvates are provided: Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.
    Type: Application
    Filed: October 27, 2011
    Publication date: February 16, 2012
    Inventors: David Gwyn COOPER, Ian Thomas Forbes, Vincenzo Garzya, Jian Jin, Yann Louchart, Graham Walker, Paul Adrian Wyman
  • BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
    Publication number: 20110207777
    Abstract: Compounds of formula (I), salts and solvates are provided, Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.
    Type: Application
    Filed: March 20, 2007
    Publication date: August 25, 2011
    Inventors: David Gwyn Cooper, Ian Thomson Forbes, Vincenzo Garzya, Jian Jin, Yann Louchart, Graham Walker, Paul Adrian Wyman
  • BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
    Publication number: 20100280071
    Abstract: Compounds of formula (I), salts and solvates are provided: Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.
    Type: Application
    Filed: March 20, 2007
    Publication date: November 4, 2010
    Inventors: David Gwyn Cooper, Ian Thomson Forbes, Vincenzo Garzya, Jian Jin, Yann Louchart, Graham Walker, Paul Adrian Wyman
  • BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
    Publication number: 20100190825
    Abstract: Compounds of formula (I) and salts and solvates are provided: wherein Uses of the compounds for the treatment of psychotic disorders and cognitive mpairment, are also disclosed.
    Type: Application
    Filed: March 20, 2007
    Publication date: July 29, 2010
    Inventors: David Gwyn Cooper, Ian Thomson Forbes, Vincenzo Garzya, Jian Jin, Yann Louchart, Graham Walker, Paul Adrian Wyman